Mental disorders in Spanish university students: Prevalence, age-of-onset, severe role impairment and mental health treatment.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 24 02 2020
revised: 08 04 2020
accepted: 27 04 2020
entrez: 21 6 2020
pubmed: 21 6 2020
medline: 16 2 2021
Statut: ppublish

Résumé

The university period carries risk for onset of common mental disorders. Epidemiological knowledge on mental disorders among Spanish university students is limited. To estimate lifetime and 12-month prevalence, persistence and age-of-onset of mental disorders among Spanish first-year university students, as well as associated role impairment and mental health treatment use. First-year university students (N=2,118; 55.4% female; mean age=18.8 years) from five Spanish universities completed a web-based survey, screening possible DSM-IV mental disorders (major depressive episode(MDE), mania/hypomania, generalized anxiety disorder(GAD), panic disorder(PD), alcohol abuse/dependence(AUD), drug abuse/dependence(DUD), and adult attention-deficit/hyperactivity disorder(ADHD)). Role impairment and treatment associated with mental disorders were assessed. Lifetime and 12-month prevalence of any possible mental disorder was 41.3%(SE=1.08) and 35.7%(SE=1.05), respectively. Persistence (i.e., ratio of 12-month to lifetime prevalence) was 86.4%(SE=1.58). Median age-of-onset was 14 for adult ADHD, 15 for mood disorders and AUD, and 16 for anxiety disorders and DUD. One third (29.2%) of 12-month disorders were associated with role impairment. Twelve-month PD (OR=4.0;95%CI=1.9-8.5) had the highest odds for role impairment. Only 12.6% of students with 12-month disorder received any mental health treatment. Twelve-month treatment was the highest among those students with 12-month GAD (OR=7.4;95%CI=3.7-14.8). The assessment of mental disorders was based on self-reports. Cross-sectional nature of the data prevents causal associations. One third of Spanish university students report a common mental disorder in the past year, and one third of those report severe role impairment. Only one out of eight students with 12-month mental disorders receives mental health treatment.

Sections du résumé

BACKGROUND
The university period carries risk for onset of common mental disorders. Epidemiological knowledge on mental disorders among Spanish university students is limited.
AIMS
To estimate lifetime and 12-month prevalence, persistence and age-of-onset of mental disorders among Spanish first-year university students, as well as associated role impairment and mental health treatment use.
METHODS
First-year university students (N=2,118; 55.4% female; mean age=18.8 years) from five Spanish universities completed a web-based survey, screening possible DSM-IV mental disorders (major depressive episode(MDE), mania/hypomania, generalized anxiety disorder(GAD), panic disorder(PD), alcohol abuse/dependence(AUD), drug abuse/dependence(DUD), and adult attention-deficit/hyperactivity disorder(ADHD)). Role impairment and treatment associated with mental disorders were assessed.
RESULTS
Lifetime and 12-month prevalence of any possible mental disorder was 41.3%(SE=1.08) and 35.7%(SE=1.05), respectively. Persistence (i.e., ratio of 12-month to lifetime prevalence) was 86.4%(SE=1.58). Median age-of-onset was 14 for adult ADHD, 15 for mood disorders and AUD, and 16 for anxiety disorders and DUD. One third (29.2%) of 12-month disorders were associated with role impairment. Twelve-month PD (OR=4.0;95%CI=1.9-8.5) had the highest odds for role impairment. Only 12.6% of students with 12-month disorder received any mental health treatment. Twelve-month treatment was the highest among those students with 12-month GAD (OR=7.4;95%CI=3.7-14.8).
LIMITATIONS
The assessment of mental disorders was based on self-reports. Cross-sectional nature of the data prevents causal associations.
CONCLUSION
One third of Spanish university students report a common mental disorder in the past year, and one third of those report severe role impairment. Only one out of eight students with 12-month mental disorders receives mental health treatment.

Identifiants

pubmed: 32560960
pii: S0165-0327(20)30627-3
doi: 10.1016/j.jad.2020.04.050
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-613

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest In the past 3 years, Dr. Kessler received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services Inc. Lake Nona Life Project. Kessler is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. Dr. Roca received research funds from Lundbeck and Janssen.

Auteurs

Laura Ballester (L)

Health Services Research Group, IMIM (Institut Hospital del Mar d´Investigacions Mèdiques), Barcelona, Spain; Girona University (UdG), Girona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Itxaso Alayo (I)

Health Services Research Group, IMIM (Institut Hospital del Mar d´Investigacions Mèdiques), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Gemma Vilagut (G)

Health Services Research Group, IMIM (Institut Hospital del Mar d´Investigacions Mèdiques), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

José Almenara (J)

University of Cádiz (UCA), Spain.

Ana Isabel Cebrià (AI)

Department of Mental Health, Corporació Sanitaria ParcTaulí, Sabadell, Spain; CIBER Salud Mental (CIBERSAM), Madrid, Spain.

Enrique Echeburúa (E)

University of the Basque Country (UPV-EHU), San Sebastián, Spain.

Andrea Gabilondo (A)

BioDonostia Health Research Institute, Osakidetza, San Sebastián, Spain.

Margalida Gili (M)

InstitutUniversitarid'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands (UIB), Palma de Mallorca, Spain.

Carolina Lagares (C)

University of Cádiz (UCA), Spain.

José Antonio Piqueras (JA)

Miguel Hernandez University of Elche (UMH), Spain.

Miquel Roca (M)

InstitutUniversitarid'Investigació en Ciències de la Salut (IUNICS-IDISPA), University of Balearic Islands (UIB), Palma de Mallorca, Spain.

Victoria Soto-Sanz (V)

Miguel Hernandez University of Elche (UMH), Spain.

Maria Jesús Blasco (MJ)

Health Services Research Group, IMIM (Institut Hospital del Mar d´Investigacions Mèdiques), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Pere Castellví (P)

School of Medicine, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.

Philippe Mortier (P)

Health Services Research Group, IMIM (Institut Hospital del Mar d´Investigacions Mèdiques), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Ronny Bruffaerts (R)

Universitair Psychiatrisch Centrum, KULeuven (UPC-KUL), Center for Public Health Psychiatry, KULeuven, Leuven, Belgium.

Randy P Auerbach (RP)

Department of Psychiatry, Columbia University, New York, New York, United States.

Matthew K Nock (MK)

Department of Psychology, Harvard University, Boston, Massachusetts, United States.

Ronald C Kessler (RC)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Alonso Jordi (A)

Health Services Research Group, IMIM (Institut Hospital del Mar d´Investigacions Mèdiques), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Pompeu Fabra University (UPF), Barcelona, Spain. Electronic address: jalonso@imim.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH